PIRAMAL PHARMA
|
PIRAMAL PHARMA Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|
| Operational & Financial Ratios | |||
| Earnings Per Share (Rs) | -1.56 | 3.17 | 8.40 |
| CEPS(Rs) | 4.11 | 8.11 | 13.88 |
| DPS(Rs) | - | - | - |
| Book NAV/Share(Rs) | 56.76 | 56.47 | 56.35 |
| Tax Rate(%) | -55.19 | 22.48 | 12.01 |
| Margin Ratios | |||
| Core EBITDA Margin(%) | 7.75 | 13.00 | 22.61 |
| EBIT Margin(%) | 2.76 | 9.35 | 17.62 |
| Pre Tax Margin(%) | -1.48 | 6.64 | 15.03 |
| PAT Margin (%) | -2.30 | 5.15 | 13.22 |
| Cash Profit Margin (%) | 6.05 | 13.17 | 21.85 |
| Performance Ratios | |||
| ROA(%) | -1.37 | 3.20 | 7.76 |
| ROE(%) | -2.77 | 6.11 | 14.90 |
| ROCE(%) | 1.95 | 7.10 | 13.06 |
| Asset Turnover(x) | 0.60 | 0.62 | 0.59 |
| Sales/Fixed Asset(x) | 0.80 | 0.83 | 0.77 |
| Working Capital/Sales(x) | 8.17 | 7.07 | 5.45 |
| Efficiency Ratios | |||
| Fixed Capital/Sales(x) | 1.26 | 1.21 | 1.29 |
| Receivable days | 80.70 | 83.94 | 91.03 |
| Inventory Days | 69.11 | 65.47 | 71.21 |
| Payable days | 149.81 | 144.76 | 162.72 |
| Valuation Parameters | |||
| PER(x) | - | - | - |
| PCE(x) | 16.66 | - | - |
| Price/Book(x) | 1.21 | - | - |
| Yield(%) | - | - | - |
| EV/Net Sales(x) | 1.89 | 0.74 | 0.55 |
| EV/Core EBITDA(x) | 15.66 | 3.98 | 2.20 |
| EV/EBIT(x) | 59.65 | 7.14 | 3.15 |
| EV/CE(x) | 0.93 | 0.38 | 0.33 |
| M Cap / Sales | 1.15 | - | - |
| Growth Ratio | |||
| Net Sales Growth(%) | 7.97 | 3.87 | - |
| Core EBITDA Growth(%) | -30.36 | -23.03 | - |
| EBIT Growth(%) | -67.21 | -38.59 | - |
| PAT Growth(%) | -149.60 | -54.98 | - |
| EPS Growth(%) | -149.29 | -62.24 | - |
| Financial Stability Ratios | |||
| Total Debt/Equity(x) | 0.81 | 0.60 | 0.52 |
| Current Ratio(x) | 1.26 | 1.33 | 1.45 |
| Quick Ratio(x) | 0.82 | 0.89 | 0.97 |
| Interest Cover(x) | 0.65 | 3.45 | 6.81 |
| Total Debt/Mcap(x) | 0.67 | - | - |
Compare Financial Ratios of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹19,850.1 Cr | 4.5% | 11.1% | 124.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹363,535.0 Cr | 0.9% | -6.6% | 58.8% | Stock Analytics | |
| CIPLA | ₹112,058.0 Cr | -1% | -5.6% | 54.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,414.0 Cr | 0.9% | 2.2% | 27.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹103,845.0 Cr | -2.2% | 6.2% | 21.2% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹98,676.3 Cr | 2.8% | -0.6% | 96.2% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 4.5% |
11.1% |
124.5% |
| SENSEX | -1.6% |
-0.5% |
19.8% |
You may also like the below Video Courses
